Susquehanna International Group
LABD icon

Susquehanna International Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Susquehanna International Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6M Sell
159,300
-23,100
-13% -$437K ﹤0.01% 5579
2025
Q4 		$3.84M Buy
182,400
+120,100
+193% +$3.26M ﹤0.01% 4463
2025
Q3 		$2.52M Buy
62,300
+55,530
+820% +$3.22M ﹤0.01% 5306
2025
Q2 		$506K Buy
6,770
+1,180
+21% +$104K ﹤0.01% 9150
2025
Q1 		$527K Buy
5,590
+1,460
+35% +$107K ﹤0.01% 8788
2024
Q4 		$299K Sell
4,130
-6,740
-62% -$412K ﹤0.01% 9834
2024
Q3 		$635K Buy
10,870
+2,820
+35% +$171K ﹤0.01% 7905
2024
Q2 		$590K Sell
8,050
-4,490
-36% -$379K ﹤0.01% 7868
2024
Q1 		$914K Sell
12,540
-13,970
-53% -$1.17M ﹤0.01% 7121
2023
Q4 		$2.57M Buy
26,510
+17,860
+206% +$3.47M ﹤0.01% 4849
2023
Q3 		$1.78M Sell
8,650
-1,080
-11% -$175K ﹤0.01% 5360
2023
Q2 		$1.4M Sell
9,730
-1,920
-16% -$287K ﹤0.01% 5924
2023
Q1 		$2.4M Sell
11,650
-16,270
-58% -$2.76M ﹤0.01% 4771
2022
Q4 		$4.82M Buy
27,920
+19,160
+219% +$3.93M ﹤0.01% 3296
2022
Q3 		$2.1M Buy
8,760
+920
+12% +$214K ﹤0.01% 4825
2022
Q2 		$3.05M Sell
7,840
-3,300
-30% -$1.65M ﹤0.01% 4039
2022
Q1 		$3.91M Sell
11,140
-3,820
-26% -$1.5M ﹤0.01% 4111
2021
Q4 		$3.85M Sell
14,960
-5,620
-27% -$1.29M ﹤0.01% 4198
2021
Q3 		$4.38M Buy
20,580
+5,440
+36% +$1.16M ﹤0.01% 4201
2021
Q2 		$2.92M Buy
15,140
+390
+3% +$87.4K ﹤0.01% 5085
2021
Q1 		$3.21M Sell
14,750
-780
-5% -$151K ﹤0.01% 4804
2020
Q4 		$3.92M Sell
15,530
-18,940
-55% -$7.22M ﹤0.01% 3848
2020
Q3 		$20.6M Buy
34,470
+32,278
+1,473% +$20.8M ﹤0.01% 1456
2020
Q2 		$1.52M Buy
2,192
+1,403
+178% +$1.76M ﹤0.01% 5010
2020
Q1 		$2.22M Sell
789
-441
-36% -$1.26M ﹤0.01% 3790
2019
Q4 		$3.04M Sell
1,230
-96
-7% -$341K ﹤0.01% 3674
2019
Q3 		$6.71M Sell
1,326
-457
-26% -$1.88M ﹤0.01% 2371
2019
Q2 		$6.42M Buy
1,783
+529
+42% +$2.23M ﹤0.01% 2389
2019
Q1 		$4.61M Buy
1,254
+427
+52% +$2.07M ﹤0.01% 2552
2018
Q4 		$7.08M Sell
827
-54
-6% -$396K ﹤0.01% 1914
2018
Q3 		$4.3M Buy
881
+275
+45% +$1.33M ﹤0.01% 2860
2018
Q2 		$3.14M Buy
606
+292
+93% +$1.77M ﹤0.01% 3323
2018
Q1 		$2.29M Buy
314
+285
+983% +$1.98M ﹤0.01% 3670
2017
Q4 		$264K Buy
29
+21
+263% +$209K ﹤0.01% 7805
2017
Q3 		$76K Sell
8
-14
-64% -$169K ﹤0.01% 8443
2017
Q2 		$305K Buy
22
+12
+120% +$231K ﹤0.01% 7568
2017
Q1 		$203K Buy
10
+5
+100% +$124K ﹤0.01% 7981
2016
Q4 		$199K Sell
5
-26
-84% -$1,000K ﹤0.01% 8653
2016
Q3 		$1.08M Sell
31
-40
-56% -$1.87M ﹤0.01% 4661
2016
Q2 		$5.2M Buy
71
+33
+87% +$2.66M ﹤0.01% 2146
2016
Q1 		$4.08M Buy
38
+8
+27% +$1.02M ﹤0.01% 2587
2015
Q4 		$1.83M Buy
+30
New +$2.29M ﹤0.01% 4218

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's LABD Position: Q1 2026 in Review

Susquehanna International Group reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 48% in Q1 2026, selling an estimated $398K and leaving 22,711 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10403.

Susquehanna International Group first reported a position in LABD in Q3 2015 and has held it in 38 quarters since. The position peaked at $13.4M in Q3 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Susquehanna International Group held 22,711 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $370K as of Q1 2026.
  • Susquehanna International Group sold 21,037 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $398K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10403 holding.
  • Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2015 and has held it in 38 quarters since.
  • Susquehanna International Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $13.4M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.